CT-011

DB05916InvestigationalProtein Based Therapies

CT-011 is a humanized monoclonal antibody directed against a B7 family-associated protein, in patients with advanced haematological malignancies. It is directed against human PD-1 (programmed cell death 1; PDCD1), with...

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in cancer/tumors (unspecified).Curator reviewed
Code names
CT-011

Resolves to

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
420Drug interactionsStructured to mechanism, not free text
Sign in
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which drugs share a target with CT-011, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account